Data reported through a smartphone app provides the first detailed description of COVID-19 in symptomatic school-aged children.
Pfizer to seek approval for a new COVID-19 booster shot
Citing concern over vaccine efficacy against emerging variants, Pfizer seeks approval for a third booster, but many are not yet convinced it is necessary.
Metabolic activators improve recovery time in patients with mild to moderate COVID-19
Small clinical trial has found that metabolic activators can improve recovery, liver health, and markers of inflammation in patients with COVID-19.
Why is there hype around the Novavax COVID-19 vaccine?
The protein-based vaccine has been highly anticipated, showing high efficacy against variants of concern.
Warmer temperatures lessen COVID-19 spread, but control measures still needed
Study shows that temperature changes have a smaller effect on transmission than policy interventions like lockdowns and social distancing.
Why are antiviral drugs for COVID-19 difficult to find?
Viruses are so varied and evolve so quickly that creating effective treatments against them becomes a daunting task.
Mixing COVID-19 vaccines might boost immunity
Emerging data from trials exploring mixing different types of vaccines demonstrate the practice is safe and could boost immunity.
US declares support for waiver of COVID-19 vaccines patents
In a historic and surprise move, this week the US declared its support for a patent waiver on COVID-19 vaccines.
Pseudoviruses help determine the success of COVID-19 vaccines and antibody therapies
Assays using pseudoviruses have been indispensable in our efforts to halt the current pandemic.
Delaying second dose of COVID-19 vaccine has benefits in the short term, but depends on immunity
The strength of immune responses after the first dose of COVID-19 vaccines could make or break this strategy and policy makers need to be able to adapt.